1. Academic Validation
  2. Novel carbohydrate modified berberine derivatives: synthesis and in vitro anti-diabetic investigation

Novel carbohydrate modified berberine derivatives: synthesis and in vitro anti-diabetic investigation

  • Medchemcomm. 2019 Feb 8;10(4):598-605. doi: 10.1039/c9md00036d.
Liwen Han 1 Wenlong Sheng 1 Xiaobin Li 1 Attila Sik 2 Houwen Lin 3 Kechun Liu 1 Lizhen Wang 1
Affiliations

Affiliations

  • 1 Biology Institute , Qilu University of Technology (Shandong Academy of Sciences) , Jinan 250014 , Shandong Province , China . Email: wlzh1106@126.com ; Email: liukechun2000@163.com ; Tel: +8613869197581.
  • 2 Institute of Transdisciplinary Discoveries , University of Pecs , Ifjúság útja 20 , Pécs , 7624 , Hungary.
  • 3 Research Center for Marine Drugs , State Key Laboratory of Oncogenes and Related Genes , Department of Pharmacy , Ren Ji Hospital , School of Medicine , Shanghai Jiao Tong University , Shanghai 200127 , China.
Abstract

Berberine is a bioactive alkaloid used in Chinese medicine and has numerous positive effects on biological systems. This paper describes the facile and highly efficient synthesis of some carbohydrate modified berberine derivatives, and conjugation of the carbohydrate moiety with berberine was finished by "click" chemistry. The cytotoxicity and anti-diabetic measurements of all berberine derivatives were accomplished on HepG2 cell lines, and the results indicated that most of the derivatives exhibit higher anti-diabetic activity than berberine. The mannose modified berberine derivative has significantly lower cytotoxicity than berberine, and the induced IC50 value of this derivative is nearly 1.5 times that of berberine. Furthermore, this mannose modified berberine derivative exhibits high anti-diabetic activity at both high and low drug concentrations, thereby indicating its potential application for the development of novel anti-diabetic drugs.

Figures